SEM analyses confirmed that the Ecological Cumulative Risk Model fit the data better than a lump sum approach.
Raman and Laser Induced Breakdown Spectroscopy analyses confirmed that the mineral consisted of calcium phosphates.
Analyses confirmed that the threat manipulation was effective in increasing the harm associated with the task.
These analyses confirmed that the signaling complexes recruited by IFNs have very similar architectures.
Detailed analyses confirmed that the NaCl porogens could be completely leached within 24 h.
Flow cytometric and confocal microscopic analyses confirmed that the QDs delivered siRNA into HeLa cells efficiently.
Sensitivity analyses confirmed that the onshore options remained the best choice.
X-ray, FTIR, and DSC analyses confirmed that the drug was dispersed inside the matrix of the nanospheres.
PCR and Southern blot analyses confirmed that the transferred fragment was successfully imported and integrated into the genome of three of these seven transgenic lines.
The N2 sorption analyses confirmed that the calcined composites have uniform mesochannels (7.58 nm), high surface area (292.51 m2/g), and large pore volume (0.55 cm3/g).
Immunofluorescence analyses confirmed that the designed prodrug localized at the hypoxic region, in contrast to conventional anticancer drugs, which localized only at the normoxic region.
